Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease

Area of Science:

• Immunodermatology
• Rheumatology
• Autoimmunity

Background:

• Progressive systemic sclerosis (scleroderma) and mixed connective tissue disease (MCTD) are autoimmune conditions with overlapping clinical and serological features.
• Immunofluorescence (IF) studies of the skin are crucial for diagnosing and understanding autoimmune rheumatic diseases.

Purpose of the Study:

• To investigate and compare epidermal nuclear immunoglobulin deposition and antinuclear antibody (ANA) staining patterns in patients with scleroderma and MCTD.
• To explore the relationship between in vitro ANA findings and in vivo antigen-antibody reactions in the skin.

Main Methods:

• Skin biopsies from 30 patients with scleroderma and 8 with MCTD underwent immunofluorescence (IF) investigations.
• Sera from these patients were analyzed for the presence and patterns of antinuclear antibodies (ANA).

Main Results:

• Speckled epidermal nuclear immunoglobulin deposition was observed in both scleroderma and MCTD patients.
• Granular IgM deposition at the dermo-epidermal junction was found in both groups, with a higher prevalence in non-exposed skin in MCTD.
• ANA were detected in 96% of scleroderma and 100% of MCTD patients, exhibiting distinct staining patterns (speckles, threads, nucleolar, centromere in scleroderma; primarily threads in MCTD).

Conclusions:

• Epidermal nuclear immunoglobulin deposition is not exclusive to MCTD but also occurs in scleroderma.
• Distinct ANA staining patterns in IF may aid in differentiating between scleroderma and MCTD.
• Further research is needed to clarify the significance of ANA titres and specificities in the in vivo reaction with epidermal nuclear antigens.